Celyad Successfully Doses First Colorectal Cancer Patient With CYAD-01 Following Preconditioning Chemotherapy
No toxicity observed to date in first patient enrolled in the amended THINK trial evaluating the safety and anti-tumor response of CYAD-01 after preconditioning chemotherapy in colorectal cancer patientsMONT-SAINT-GUIBERT, Belgium, Sept. 05, 2018 (GLOBE …